Study S002393

The Effect of Inulin on Cardiometabolic Risk Factors in Individuals Using Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Medications for Weight Loss: a Randomized Double-blind Controlled Trial

ClinicalTrials.gov record

Registration

Registration: NCT07611552
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: QUADRUPLE
Status: NOT_YET_RECRUITING
Enrollment: 600
Start: 2026-06
Primary completion: 2026-11
Lead sponsor: Huazhong University of Science and Technology
Conditions: Obesity & Overweight
Interventions: DIETARY_SUPPLEMENT:inulin (prebiotics); DIETARY_SUPPLEMENT:Placebo Comparator: maltodextrin
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

change in concentrations of blood lipid levels in millimole per liter (mmol/L). [From enrollment to the end of intervention at 4 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.